Bio-Rad Reports Mixed Q4 2025 Results Amid Funding Pressures and Margin Challenges
Feb 13, 2026
Bio-Rad Laboratories reported Q4 2025 revenue of $693.2 million, up 3.9%, driven by Clinical Diagnostics growth, while Life Science sales declined 2.6% due to constrained academic and biotech funding. Gross and operating margins fell below expectations.